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Abstract 29 
Producing specialised metabolites such as antibiotics, immunosuppressives, anti-cancer 30 
agents and anti-helminthics draws on primary metabolism to provide the building blocks for 31 
biosynthesis. The growth phase-dependent nature of production means that producing 32 
organisms must deal with the metabolic conflicts of declining growth rate, reduced nutrient 33 
availability, specialised metabolite production and potentially morphological development. In 34 
recent years our understanding of gene expansion events, integration of metabolic function 35 
and gene regulation events that facilitate the sensing and responding to metabolite 36 
concentrations has grown, but new data are constantly expanding our horizons. This review 37 
highlights the role evolutionary gene/pathway expansion plays in primary metabolism and 38 
examine the adoption of enzymes for specialised metabolism. We also look at recent insights 39 
into sensing and responding to metabolites. 40 
 41 
Highlights 42 
* The building blocks for specialised metabolite production are derived from primary 43 
metabolism and their supply is a key, yet often overlooked, component of the regulation of 44 
biosynthesis.  45 
*  Gene duplication and horizontal gene transfer have played a central role in the evolution 46 
and adaption of metabolism for the production of specialised metabolism. This can either be 47 
via adaptive expansion across the genome or specifically located in biosynthetic gene 48 
clusters. The adoption of primary metabolic enzymes into existing gene clusters may also 49 
facilitate the evolution of new specialised metabolites. 50 
* Advances in ‘omics technologies have enabled us to use the wealth of genomic, 51 
transcriptomic and metabolomic data to model metabolism and survey metabolic capabilities, 52 
yet detailed reductionist approaches studying kinetics are often still required to fully elucidate 53 
the physiological role played an enzyme. 54 
 55 
 56 
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Introduction 57 
All organisms on earth are comprised of chemicals. Bacteria are no different. Indeed, there is 58 
a highly conserved collection of chemicals, the products of central metabolic pathways, which 59 
are shared by most bacteria. Remarkably these ‘primary metabolites’ number only several 60 
hundred compounds in most bacteria. Historically, the separation of ‘primary’ and ‘secondary’ 61 
metabolism was widely adopted across biology, yet the implication of this is that secondary 62 
metabolism is less important than primary metabolism [1,2]. This view has been changing 63 
recently and reflects that ‘secondary metabolites’ have specialised roles in the lifecycle of an 64 
organism and reflect adaptive functions in specific niches. It is these specialised metabolites 65 
that contribute to the huge structural and chemical diversity we see in the natural products of 66 
micro-organisms and in particular the Actinobacteria. These metabolites expand the functional 67 
capability of these organisms in the natural environment and it is this functionality that we have 68 
been able to exploit as clinically useful drug-molecules such as antibiotics, 69 
immunosuppressives and anticancer agents. The role precursor supply plays in the production 70 
of specialised metabolites is often ignored. Here we will discuss the role of primary metabolism 71 
in specialised metabolism in Actinobacteria and how expanding genetic repertoires, 72 
integrating functionality and sensing and responding to metabolite concentrations affects and 73 
facilitates the production of specialised metabolites.  74 
The production of complex specialised metabolites is by dedicated biosynthetic gene clusters 75 
(BGCs) and is growth phase dependent, often being triggered by the limitation of a particular 76 
nutrient. In Actinobacteria such as Streptomyces production is intimately linked with 77 
morphological development [3-5]. The biosynthetic precursors of all specialised metabolites 78 
are supplied from pools of primary metabolites, directly linking primary and specialised 79 
metabolism [4-6]. Drawing on these pools of primary metabolites for specialised metabolite 80 
production is likely to create significant metabolic conflict in producing organisms, where 81 
declining extracellular nutrients may limit intracellular processes, such that complex regulatory 82 
systems are required to ensure cellular integrity [4]. Understanding the molecular mechanisms 83 
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of how organisms cope with this is fundamental to our continued exploitation of the specialised 84 
metabolism of Actinobacteria.  85 
 86 
Expanding 87 
Genome analysis of Streptomyces reveals the presence of multiple genes predicted to encode 88 
identical primary metabolic enzyme functions [4]. This is often referred to as redundancy, 89 
hypothesised to provide robustness and evolvability in metabolism [7,8]. ‘Redundancy’, 90 
however, is a misleading term, suggesting non-essentiality, with the large genomes of 91 
specialised metabolite producing organisms providing multiple routes to many metabolic 92 
intermediates. This may be adaptive under certain environmental conditions, therefore 93 
‘contingency’, ‘metabolic flexibility’ or ‘enzyme expansion’ may be more suitable terms [9,10]. 94 
This would also provide a framework to account for the ‘moonlighting’ enzymes, with catalytic 95 
promiscuity that facilitates the diversification of metabolism, which may have enabled the 96 
extensive specialised metabolism in bacteria to evolve [11-13] (Fig. 1). 97 
Extensive primary metabolic enzyme expansion was recently surveyed across the whole 98 
Actinobacterial phylum using a phylogenomic approach to identify primary metabolic gene 99 
duplication events in the so called, metabolically ‘talented’ strains, i.e. those strains that have 100 
extensive specialised metabolism [4]. The conventional view is that gene duplication is the 101 
main source of gene expansion events in bacterial genomes. Following duplication genes are 102 
thought to diverge by neo-functionalisation (gain of new functions by duplicates) or sub-103 
functionalisation, where duplicates undergo complementary degeneration such that both 104 
copies are required to complement the function of the ancestral gene. Recently it has been 105 
shown that horizontal gene transfer (HGT) plays the predominant role in gene expansion in 106 
bacteria and may be subject to similar divergence events [9] (Fig. 1). Remarkably, in 107 
Streptomyces only two central carbon metabolic enzymes have been expanded through 108 
duplication, despite the extensive gene expansions observed. These are phosphofructokinase 109 
(pfk), with two of the three genes arising from a duplication event [14] and pyruvate kinase 110 
(pyk) [4]. A further 12 enzymes (a total of 48 genes) from glycolysis, TCA cycle, and amino 111 
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acid metabolism exhibit gene expansion but phylogenetic analysis reveals that the majority of 112 
these had expanded via HGT. It is generally considered that gene expansion events increase 113 
genetic robustness to mutation facilitating evolutionary innovation [8], adaptation and 114 
ultimately increase strain fitness [4]. Detailed genetic and biochemical analysis of both pfk and 115 
pyk indicated that deletion mutants may exhibit antibiotic overproduction phenotypes. These 116 
data suggest that perturbation of the fine balance between duplicates in primary metabolism 117 
can affect precursor supply and stress responses, with each duplicate having distinct 118 
physiological roles. Moreover, in the case of pyk, the distinct physiological roles for each 119 
duplicate is achieved by allosteric regulation and substrate affinity, rather than through 120 
developmental expression or activation under specific environmental conditions [4].  121 
Application of genome scale metabolic modelling to these expanded gene families often 122 
misses the nuances of enzyme expansion events, as pathway flux is often combined in a 123 
single output and does not reflect the fine levels of control for each gene product. In an age of 124 
genome scale studies, this tells us that there is still a need for reductionist, single enzyme 125 
biochemical studies to really elucidate biological function.  126 
As outlined above, gene duplications may contribute less to gene expansion events in 127 
Actinobacteria than previously thought and little consideration has been given to the role of 128 
HGT in metabolic gene expansion [10,15]. Conventional thoughts on biological innovation are 129 
that orthologs exhibit conserved functionality and paralogs tend to diverge in functionality. 130 
Integrating HGT into studies of gene expansion events has been difficult to implement. 131 
However, it has recently been shown that horizontally acquired genes for metabolism may 132 
enable the evolution of existing metabolic functions and diversification of substrate specificity 133 
which may be more common that previously appreciated [10]. Using a combination of 134 
approaches spanning phylogenetics, structural biology, biochemistry and bioinformatics Cruz-135 
Morales et al., [13] showed that acquisition of key metabolic function may be shaped by 136 
positive selection, narrowing substrate specificity of ancient, promiscuous genes, which exhibit 137 
highly conserved structural features [10]. In Streptomyces the clustering of histidine and 138 
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tryptophan genes on the chromosome reflects the lack of a trpF gene, with the dual 139 
(promiscuous) functional enzyme PriA (a ~50% homolog of hisA) enabling biosynthesis of 140 
both histidine and tryptophan [16]. These studies suggest that despite gene expansion events 141 
being common, convergent evolutionary processes are supporting primary metabolic diversity 142 
in Actinobacteria.  143 
Whilst it is common that HGT can expand pathways in primary metabolism concomitantly 144 
increasing robustness and adaptive function, there are increasing examples of gene co-145 
option/adoption directly into specialised metabolite biosynthetic clusters (Fig. 1). Expanding 146 
and exploiting evolutionary guided approaches to understand specialised metabolite 147 
production has yielded some insight into this process. Using a database of ‘precursor supply 148 
central metabolic pathway’ (PSCP) enzymes, Cruz-Morales et al., [13,17] were able to 149 
demonstrate the repurposing of primary metabolic enzymes into the BGCs for specialised 150 
metabolites. Identification of a homologue of aroA, the 3-phosphoshikimate-1-151 
carboxyvinyltransferase usually involved in aromatic amino acid biosynthesis, associated with 152 
a two gene polyketide synthase (PKS) gene system [13] suggested that there may be interplay 153 
between the enzymes. Synteny between S. coelicolor and S. lividans further suggested that 154 
there may be a functional linkage between the PKS genes and a cluster of genes required for 155 
phosphonate biosynthesis in proximity to some arsenate resistance genes suggesting that an 156 
arseno-organic metabolite may be the product of the pathway. Functional analysis of the 157 
cluster using genetics and biochemistry confirmed the presence of an arseno-organic 158 
molecule in the supernatant of S. coelicolor and S. lividans which was lost when a deletion 159 
mutant of the aroA homologue was constructed. The conceptual loop for this so called 160 
‘EvoMining’ approach was closed with the widespread identification of similar BGCs in other 161 
Streptomyces species [13]. Further examples of pathway specific precursor supply enzymes 162 
has recently been shown for the polyketide immunosuppressive FK506, with the identification 163 
of a pathway specific crotonyl-CoA carboxylase/reductase in S. tsukubaensis [18]. Two 164 
homologous ccr genes were identified, with ccr1 being located within the ethylmalonyl-CoA 165 
biosynthetic operon, with a second copy allR being located on the fringes of the FK506 BGC. 166 
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Deletion of ccr1 results in a strain that cannot grow using acetate as a sole carbon source, 167 
complementation of the ethylmalonyl-CoA biosynthetic operon with allR, creating a chimeric 168 
operon, is unable to support FK506 production. These data reinforce the idea that there are 169 
distinct functional roles for duplicate genes and there is likely physiological partitioning.  170 
 171 
Integrating 172 
Given the rise in antimicrobial resistant infections, there is an urgent need to discover new 173 
antimicrobial drugs and to overproduce existing molecules, which may provide scaffolds for 174 
semi-synthesis. Understanding the integration of the pathways that supply precursors to 175 
specialised metabolism will facilitate strategies to enhance production of specialised 176 
metabolites [4,19]. The wealth of genomic data available enables rapid genome scale 177 
modelling (GSM) of strains. Recently a GSM was produced for S. leeuwenhoekii, an organism 178 
that produces a novel ansamycin-like polyketide called chaxamycin and an additional 179 
polyketide, with anti-cancer activity called chaxalactin [20]. GSMs allow the identification of 180 
potential metabolic engineering targets to enhance specialised metabolite production. The 181 
work of Razmilic et al [20] suggested that the deletion of genes that encode acetyl CoA 182 
consuming reactions and increasing the production of acetyl CoA and malonyl CoA and 183 
pentose phosphate pathway intermediates may be routes to increasing chaxamycin and 184 
chaxalactin. There is a cautionary note relating to these studies, often plasticity and 185 
contingency in metabolism means that targets for metabolic engineering frequently do not 186 
yield the expected increase in production [21], validated targets may not show up in GSM 187 
studies [22,23] or activation of previously silent biosynthetic gene clusters may occur [4].  188 
Enhancing supply of primary metabolic substrates can also be achieved through inhibition of 189 
key cellular processes – what has been termed a ‘metabolic perturbation’ approach. Recently 190 
the inhibition of fatty acid biosynthesis in model and industrial strains of Streptomyces was 191 
used as a route to enhancing specialised metabolite production – in some cases achieving 192 
titre increases of 40% for polyketides [6,24] – demonstrating that primary metabolism limits 193 
the production of specialised metabolites. Remarkably, inhibitors of fatty acid biosynthesis 194 
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such as ARC2 or Triclosan may not be simply increasing the fatty acid pool for polyketide 195 
synthesis through the limitation of fatty acid synthesis but through the increase in pools of 196 
certain unsaturated fatty acids [25]. Using a similar ‘metabolic perturbation’ approach Tanaka 197 
et al., [6] hypothesised that disruption of ribosomal activity, through ribosomal inhibiting drugs 198 
would positively affect non-ribosomal peptide (NRP) synthesis by increasing the pool of 199 
intracellular amino acids that could then be targeted to the NRP machinery rather than protein 200 
synthesis. Using sub-inhibitory concentrations of chloramphenicol, these authors showed up 201 
to 2-fold increases in NRP specialised metabolites [6] and achieving up to 6-fold increases in 202 
cellular amino acid pools.  203 
 204 
Sensing and Responding 205 
It has long been known that supply of phosphate, nitrogen and carbon can have profound 206 
effects on the production of specialised metabolites. In recent years the application of global 207 
‘omics studies have shed increasing detail on the complexity of these interactions. The 208 
negative role played by glucose has long been known, but it is now becoming clear that the 209 
concentrations of these extracellular metabolites may down-regulate specialised metabolism, 210 
yet the exact molecular mechanism remains elusive [26-28] (Fig. 2). In Streptomyces the 211 
regulation of carbon catabolite repression (CCR) not directed by a phosphotransferase system 212 
(PTS) and is directly through glucose kinase (Glk) and its transport through the permease, 213 
GlcP [29]. Understanding how integrating the function of a Glk/GlkP system with the PTS for 214 
fructose and N-acetyl-glucosamine (GlcNAc) to control global carbon metabolism remains to 215 
be elucidated in Streptomyces [30-32]. There are still fundamental gaps in our knowledge of 216 
how Streptomyces regulate specialised metabolism with preferred carbon sources, the role of 217 
carbon catabolite repression and how this may be overcome in industrial situations. Recent 218 
progress has proposed that there are at least two mechanisms of regulation – one Glk-219 
dependant and one Glk-independent (glucose dependent) [27], with the emphasis being on 220 
the second mechanism, where glucose may also stimulate additional carbon transporters 221 
[23,27,33], suggesting that there is a wider eco-evolutionary mechanism at play. Whilst the 222 
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use of carbon sources such as glucose and glycerol are favoured in industrial scenarios, 223 
where rapid growth and high levels of biomass are desired, the negative effects of such on 224 
specialised metabolism suggests that perhaps a deeper understanding of the ecology of 225 
specialised metabolite producers may enable novel over production strategies to be 226 
developed. The GntR-like regulator, DasR is one metabolite responsive regulator that links 227 
primary and specialised metabolism and which is known to bind directly to pathway specific 228 
regulators of specialised metabolites [23,32]. The sugar metabolism of streptomycetes is 229 
geared towards the amino sugar, GlcNAc rather than glucose [32], reflecting the ecology of 230 
an organism that has evolved in an environment that has an abundance of the GlcNAc 231 
polymer, chitin. GlcNAc can act as a carbon and nitrogen source in cells, but recent work has 232 
shown that DasR may be a central player in how responses to carbon, nitrogen and phosphate 233 
availability occur in the cell, affecting global primary metabolism and directly affecting the 234 
transcription of specialised metabolite BGCs [34,35]. The phosphate responsive PhoR-PhoP 235 
two component regulatory system and the orphan response regulator GlnR act as master 236 
regulators of phosphate uptake and global nitrogen metabolism respectively [36-40], with 237 
similarity and overlap in their binding sites [5]. PhoR-PhoP and GlnR are both known to have 238 
profound effects on specialised metabolite production, providing a regulatory link to well-239 
studied physiological responses, however it is becoming apparent that other, less well studied 240 
nutrient sources may also have profound effects on specialised metabolism. A recent example 241 
of this is the role played by global sulphur metabolism in specialised metabolite precursor 242 
supply affecting the synthesis of albomycin, which contains a sulphur moiety [41].  243 
Often overlooked in specialised metabolism is the requirement for maintenance of cofactor 244 
supply [21] and redox poise [42] to enable balancing of the substrate oxidation, energy supply 245 
and as key allosteric regulators of primary metabolic enzymes. Building on this, the work of 246 
Tala et al., [43] has recently shown that a modulator of oxidative stress may act on gene 247 
expression in central carbon metabolism. Tala et al., [43] demonstrated that a conserved iron-248 
containing Pirin protein, PirA could affect beta-oxidation pathways, disrupting polyketide 249 
precursor supply in S. ambofaciens. This action is brought about through the negative 250 
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regulation of a long chain fatty acid dehydrogenase which catalyses the first step of the beta-251 
oxidation pathway. The identification of these effects of pirin suggests that there is still much 252 
to be discovered in the links between primary and specialised metabolism. 253 
 254 
Summary 255 
There is an intimate link between the biosynthesis of specialised metabolites and the supply 256 
of building blocks from primary metabolism. It is clear that producing organisms have invested 257 
a huge amount of genome content to link these processes in terms of expanding gene content 258 
to play specialised physiological roles, integrating metabolism to enable production to proceed 259 
and sensing and responding to the extracellular and intracellular environment to ensure 260 
appropriate production. There is still much to be learned about how these systems fully 261 
integrate, but it is clear that there is increasing interest in using metabolic engineering and 262 
synthetic biology to enable the exploitation of bacterial specialised metabolism. 263 
 264 
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Figure Legends 440 
Fig. 1.  Gene expansion events. Gene A encodes for a primary metabolic enzyme. It 441 
may have promiscuous function, expanding its role in metabolism by acting in 442 
multiple pathways (Pathway 1 and Pathway 2). Its functionality can be expanded 443 
by HGT, gene duplication followed by neo- or sub-functionalisation in primary 444 
metabolism or the gene duplicate may be adopted directly into a specialised 445 
metabolite cluster. 446 
 447 
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Fig. 2  Integrating metabolic function. Extracellular nutrient uptake provides the 449 
material for interconversion by primary metabolism. This provides the building 450 
blocks for cellular function, sensing and responding to these enables the 451 
regulation of specialised metabolism and the integration of metabolic function. 452 
 453 
 454 
